| TGA Action ID |
RC-2026-RN-00002-1 |
| Type of Product |
Medicine |
| Product Name/Description |
Bortezomib 1.9mg in syringe (Terumo) for Intravenous use
Batch Number: BB251120424
Expiry Date: 31/01/2026
ARTG Exempt |
| ARTG Number |
|
| Action Type |
Recall |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
The incorrect Route of Administration was supplied. Intravenous use was supplied instead of the requested Subcutaneous use.
Given the nature of the product, this action was undertaken prior to TGA notification (Immediate Market Action as defined within the PRAC). |
| Instructions for Customers/Users |
The batch was distributed to the customer on 01/12/2025, and was nominated to be administered to the patient on 04/12/2025.
Customers should inspect their stock immediately to determine if they have any remaining stock and if so, quarantine to prevent further use. The affected batch can be discarded as cytotoxic waste.
For further information customers should contact their Key Account Manager. |
| Action Commencement Date |
13/01/2026 |
| Responsible Entity |
|
| Contact Information |
03 9565 4400 - Slade Health |